New Owner
Bristol-Myers Squibb - Padlock Therapeutics
Bristol-Myers Squibb acquires Padlock Therapeutics
Announced: March 23, 2016
Closed: April 01, 2016
Type: Acquisition
Disposition: Combined
Status: Complete
Amount: $ 600,000,000